Skip to content
Company Analysis

InspireMD Inc. NSPR

A comprehensive view of key metrics, scores, and financial health for InspireMD Inc.

Overview of InspireMD, Inc.

NSPR NCM
Healthcare Medical Devices Framework: Medical Devices & Diagnostics Micro Cap
InspireMD, Inc. (NSPR), is a Micro Cap company, in the Medical Devices industry, last closed at $0.73, about 0.0% overvalued vs fair value, -68.5% 1Y return, ranked 811/1122 in sector.
USD 0.73
0.00%
(Delayed)
• Vol 90d: 57.6%
Market Cap
$36.30M
Enterprise Value
$30.65M
Overall Score
View breakdown
Overall
Growth
Fair
Profitability
Weak
Health
Fair
Efficiency
Fair
Valuation
Weak
Growth
Fair
Profitability
Weak
Health
Fair
Efficiency
Fair
Valuation
Weak
Completeness: 82%
Confidence: 87%
Updated: Mar 8
Top Beats

Quick Facts

Website https://www.inspiremd.com
HQ Miami, FL
Employees 66
Fiscal year Dec 31

Next Events

No upcoming events available.

Fair Value Snapshot

Bear Base Bull
$-1
$-1
$-1
Current: $0.73

Engine Room Money Flow™

Micro Cap

Medical Devices & Diagnostics - Where revenue goes and how value is created

Flow Steps
Total Revenue
$7.0M
13%%
Gross Profit
$1.5M
-16.7%%
Operating Income (GAAP)
$-33.5M
-58.5%%
EBITDA
$-33.2M
-58.9%%
Money Flow Bridge
Flow Direction: Money moves from left to right
Components: Breakdown shows composition of each stage
Industry-Specific: Medical Devices & Diagnostics

Quality & Reliability Indicators

Gross Margin
21.5%
Poor

Gross Profit / Revenue — primary moat signal for MedTech. ≥65% indicates IP-protected consumables with strong pricing power.

Locked Metric
-
Premium
Locked Metric
-
Premium
Locked Metric
-
Premium
Locked Metric
-
Premium
Locked Metric
-
Premium
Locked Metric
-
Premium

Where It Leaks

Cash Flow Health critical
Significant cash flow inefficiencies identified. Multiple high-impact leaks require attention.
1
Active Leaks
0/1
Improving
0
High Impact
1
Critical
Moat Analysis Medical Devices & Diagnostics

Competitive Advantage Assessment

Evaluating InspireMD Inc.'s durable competitive advantages across 6 defense dimensions

Overall Moat Strength
23
/100
Weak
Scores based on quantitative metrics and qualitative factors

Upgrade to unlock interactive defense details

Premium access

Unlock full defense analysis

Get key signals, strengths, and risks for every moat dimension.

Upgrade to Premium Unlock all moat defenses and evidence.

Pricing Power & Consumable Moat

Weak
17
Premium
Unlock full defense details

See key signals plus strengths and risks for this moat dimension.

Upgrade for full defense analysis Premium-only evidence and insights.
For informational purposes only. Not investment advice.

Trade-Off Ledger™

Where management spends the performance budget - Growth, Profitability, or Safety

Healthcare: MedTech (Devices & Supplies) vs Industry Peers 83% Coverage
Trade-Off Triangle Visualization A ternary plot showing NSPR's balance between Growth (55.7%), Profitability (16.4%), and Safety (28.0%). Growth 56% Safety 28% Profitability 16%

Click axes to expand details. Marker shows current allocation.

3-Year Trend Analysis Locked
Upgrade to unlock the full 3-year trend analysis and deltas.

Growth

56th percentile vs peers
57
Key Signals
Rev Growth YoY 13.0% 63p Revenue CAGR 3Y 16.0% 68p EPS Growth YoY 7.0% 37p Asset Growth YoY -1.8% 50p
Strengths

No notable strengths identified for this axis.

Risks

No significant risks identified for this axis.

Profitability

16th percentile vs peers
17
Key Signals
Strengths
Risks
Premium
Unlock full Profitability drilldowns

See the signal-level drivers and insights behind this axis. Upgrade to reveal the full Trade-Off Ledger.

Upgrade Now

Safety

28th percentile vs peers
29
Key Signals
Strengths
Safety drilldowns are available to premium members.

Two Futures

Scenario-based fair value ranges for InspireMD Inc..

Loading valuation model...
Unable to Compute Fair Value

This company cannot be valued using standard models.

What this means: The Scenario Theatre requires financial data (revenue, cash flow, shares outstanding) to calculate fair value estimates. This data may be unavailable for:

  • Recently listed companies (IPOs, SPACs)
  • Shell companies or holding companies
  • Companies that haven't filed recent financials
  • Foreign companies with limited data coverage
X.X%
X%XX%
X.X%
-XX%XX%
XX.X%
-XX%XX%
Adjust the sliders above to explore different valuation scenarios.
Unlock Premium
Reveal the full Scenario Theatre
See live sliders, narratives, and full Bear/Base/Bull outcomes.
Upgrade Now
Bear
-
- - -
- upside
-
Base
$-0.86
- - -
- upside
Snapshot base estimate
Bull
-
- - -
- upside
-
Fair Value Range Current: $-
$- $- $-
Actions & Info
Send Feedback
Please select a category.
0/1000